多利益相关者研究伙伴关系中识别和邀请个人时需要考虑的因素。
Factors to Consider During Identification and Invitation of Individuals in a Multi-stakeholder Research Partnership.
机构信息
Cochrane Pain Palliative and Supportive Care Group, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, Royal United Hospitals NHS Foundation Trust, Bath, UK.
出版信息
J Gen Intern Med. 2022 Dec;37(16):4047-4053. doi: 10.1007/s11606-022-07411-w. Epub 2022 Feb 7.
BACKGROUND
Health research teams increasingly partner with stakeholders to produce research that is relevant, accessible, and widely used. Previous work has covered stakeholder group identification.
OBJECTIVE
We aimed to develop factors for health research teams to consider during identification and invitation of individual representatives in a multi-stakeholder research partnership, with the aim of forming equitable and informed teams.
DESIGN
Consensus development.
PARTICIPANTS
We involved 16 stakeholders from the international Multi-Stakeholder Engagement (MuSE) Consortium, including patients and the public, providers, payers of health services/purchasers, policy makers, programme managers, peer review editors, and principal investigators.
APPROACH
We engaged stakeholders in factor development and as co-authors of this manuscript. Using a modified Delphi approach, we gathered stakeholder views concerning a preliminary list of 18 factors. Over two feedback rounds, using qualitative and quantitative analysis, we concentrated these into ten factors.
KEY RESULTS
We present seven highly desirable factors: 'expertise or experience', 'ability and willingness to represent the stakeholder group', 'inclusivity (equity, diversity and intersectionality)', 'communication skills', 'commitment and time capacity', 'financial and non-financial relationships and activities, and conflict of interest', 'training support and funding needs'. Additionally, three factors are desirable: 'influence', 'research relevant values', 'previous stakeholder engagement'.
CONCLUSIONS
We present factors for research teams to consider during identification and invitation of individual representatives in a multi-stakeholder research partnership. Policy makers and guideline developers may benefit from considering the factors in stakeholder identification and invitation. Research funders may consider stipulating consideration of the factors in funding applications. We outline how these factors can be implemented and exemplify how their use has the potential to improve the quality and relevancy of health research.
背景
越来越多的健康研究团队与利益相关者合作,以产生相关、可及且广泛使用的研究成果。之前的工作已经涵盖了利益相关者群体的识别。
目的
我们旨在为健康研究团队制定一些因素,以便在多利益相关者研究伙伴关系中识别和邀请个人代表,旨在形成公平和知情的团队。
设计
共识开发。
参与者
我们邀请了来自国际多利益相关者参与(MuSE)联盟的 16 名利益相关者,包括患者和公众、提供者、卫生服务支付者/购买者、政策制定者、项目管理者、同行评审编辑和主要研究者。
方法
我们让利益相关者参与因素的制定,并作为本文的合著者。我们使用改良 Delphi 方法收集了利益相关者对初步列出的 18 个因素的看法。通过两轮反馈,使用定性和定量分析,我们将这些因素集中到十个因素中。
主要结果
我们提出了七个非常理想的因素:“专业知识或经验”、“代表利益相关者群体的能力和意愿”、“包容性(公平、多样性和交叉性)”、“沟通技巧”、“承诺和时间能力”、“财务和非财务关系和活动,以及利益冲突”、“培训支持和资金需求”。此外,还有三个因素是理想的:“影响力”、“研究相关价值观”、“以前的利益相关者参与”。
结论
我们为研究团队在多利益相关者研究伙伴关系中识别和邀请个人代表提供了一些因素。政策制定者和指南制定者可能会受益于在利益相关者识别和邀请中考虑这些因素。研究资助者可能会考虑在资助申请中规定考虑这些因素。我们概述了如何实施这些因素,并举例说明了它们的使用有可能提高健康研究的质量和相关性。